Mainz Biomed N.V Cash Flow Statement (2020-2025) | MYNZ

Cash Flow Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025
Operating Activities
Net Income -5.66M-6.94M-5.60M-8.19M-6.56M-8.25M-6.30M-5.18M
Depreciation and Depletion 0.11M0.13M0.13M
Share-based Compensation 2.86M2.82M2.59M1.56M0.92M1.18M1.09M0.82M
Gains from Sales and Divestitures 7.68M6.43M6.92M
Gains from Investment Securities -11.66M
Asset Writedowns and Impairment -470.000.05M-1.000.04M
Cash from Operations -2.76M-3.70M-3.60M-4.71M-5.66M-5.12M-6.51M-4.66M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.09M0.09M
Depreciation & Amortization (CF) 0.03M0.03M0.07M0.03M0.29M0.17M0.20M0.20M
Change in Working Capital
Change in Receivables 0.11M-0.18M0.33M-0.10M0.26M0.03M0.37M-0.14M0.09M-0.20M
Change in Inventory 0.04M0.18M0.27M0.39M0.49M0.61M-0.51M0.37M-0.62M
Change in Account Payables 0.78M0.07M1.21M-0.34M2.92M-0.39M4.72M3.10M3.18M-2.62M2.30M-1.75M
Other Working Capital Changes 0.10M0.23M-0.18M0.99M0.05M0.32M1.05M1.20M-0.30M1.18M0.20M
Investing Activities
Capital Expenditures -0.08M-0.18M-0.39M1.30M-0.90M-0.12M-0.01M2.24M
Change in Intangibles 3.27M0.87M0.40M0.73M-0.85M0.69M0.20M
Cash from Investing Activities -0.08M-0.18M-0.39M-0.01M-1.40M-0.12M-0.11M-0.26M
Financing Activities
Cash from Financing Activities 24.11M-0.02M-0.04M-0.11M0.77M5.42M4.57M3.47M
Dividend Payments
Dividends Paid - Preferred 40.00
Additional items
Exchange Rate Effect -0.03M-0.07M0.03M-0.03M0.00M-0.12M0.46M-0.80M
Change in Cash 21.25M-3.97M-4.00M-4.86M-6.28M0.05M-1.59M-2.25M
Beginning Cash Balance 0.12M8.73M8.73M29.97M26.01M22.01M17.14M17.09M18.73M9.32M7.07M6.24M1.91M
Free Cash Flow -2.68M-3.52M-3.21M-6.01M-4.76M-5.00M-6.49M-6.89M
Net Cash Flow 21.28M-3.89M-4.03M-4.84M-6.29M0.18M-2.05M-1.45M